ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,859,000 | – | 167,474 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,259,840 | $2,054,000 | 1.16% |
| AMERICAN FINANCIAL GROUP INC | 1,480,000 | $2,412,000 | 0.64% |
| Altium Capital Management LP | 1,118,000 | $1,822,000 | 0.48% |
| Vanguard Capital Wealth Advisors | 437,900 | $457,000 | 0.31% |
| Mesirow Financial Investment Management, Inc. | 18,894 | $31,000 | 0.09% |
| Nantahala Capital Management | 1,209,338 | $1,971,000 | 0.06% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $3,414,000 | 0.05% |
| Altshuler Shaham Ltd | 1,157,540 | $1,896,000 | 0.01% |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $954,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 41,642 | $68,000 | 0.01% |